Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
10 pending office actions • 2 clients • 10 examiners • 8 art units • 0 of 10 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days
K&L Gates LLP-Chicago has 252 pending office actions in Chemistry & Materials and 34332 career applications. Its resolved allowance rate is 84.49%, and the average office actions per allowance is 3.82. The profile shows a large active workload alongside the broader application record associated with the practice.
Pending actions reflect matters still requiring attention, while the allowance rate and office-action average describe resolved prosecution activity. The historical record indicates that allowance has involved repeated examination interactions, making response coordination and amendment discipline important. For practitioners, the technology focus also makes experimental evidence, compositional boundaries, and process limitations relevant to prosecution planning.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 6 (60%) |
| §112 only | 1 (10%) |
| Multi-statute (no §101) | 3 (30%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHRISTIANSON, SKYLAR LINDSEY | 1 | 60.9% | +25.4% |
| LEVY, BRANDON WILLIAM | 1 | 62.9% | +46.5% |
| MARSH, OWEN LEWIS | 1 | 66.7% | +50.0% |
| VALLE, ERNESTO | 1 | 65.8% | +32.9% |
| SHARMA, YASHITA | 1 | 81.7% | +24.9% |
| PELTON, NATHANIEL R | 1 | 74.5% | +18.9% |
| BASQUILL, SEAN M | 1 | 38.8% | +21.7% |
| TOTH, KAREN E | 1 | 46.4% | +25.8% |
| MANNAN, MIKAIL A | 1 | 68.3% | +24.0% |
| EISEMAN, LYNSEY C | 1 | 49.1% | +39.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18539423 | BIORESORBABLE CORNEAL IMPLANTS | SHARMA, YASHITA | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19030052 | PHOTOACTIVATION SYSTEMS AND METHODS FOR CORNEAL CROSS-LINKING TREATMENTS | CHRISTIANSON, SKYLAR LINDSEY | — |
| 18663943 | PHOTOACTIVATION SYSTEMS AND METHODS FOR CORNEAL CROSS-LINKING TREATMENTS | MARSH, OWEN LEWIS | — |
| 18540296 | INTRAOCULAR PHYSIOLOGICAL SENSOR | PELTON, NATHANIEL R | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 13438705 | CONTROLLED CROSS-LINKING INITIATION AND CORNEAL TOPOGRAPHY FEEDBACK SYSTEMS FOR DIRECTING CROSS-LINKING | EISEMAN, LYNSEY C | 20d |
| 19030052 | PHOTOACTIVATION SYSTEMS AND METHODS FOR CORNEAL CROSS-LINKING TREATMENTS | CHRISTIANSON, SKYLAR LINDSEY | — |
| 18913142 | INSERTION SYSTEM FOR DELIVERY OF ACTIVE PHARMACEUTICAL AGENTS INSIDE THE EYE | LEVY, BRANDON WILLIAM | — |
| 18663943 | PHOTOACTIVATION SYSTEMS AND METHODS FOR CORNEAL CROSS-LINKING TREATMENTS | MARSH, OWEN LEWIS | — |
| 18606217 | OPHTHALMIC CREAM FORMULATIONS AND THEIR USES | VALLE, ERNESTO | — |
| 18539423 | BIORESORBABLE CORNEAL IMPLANTS | SHARMA, YASHITA | — |
| 18540296 | INTRAOCULAR PHYSIOLOGICAL SENSOR | PELTON, NATHANIEL R | — |
| 18359642 | OPHTHALMIC TOPICAL CREAM FORMULATIONS AND USES THEREOF | BASQUILL, SEAN M | — |
| Art Unit | Apps |
|---|---|
| 3796 | 2 |
| 3774 | 2 |
| 3792 | 1 |
| 3781 | 1 |
| 1623 | 1 |
| 2859 | 1 |
| 1614 | 1 |
| 3791 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19030052 | PHOTOACTIVATION SYSTEMS AND METHODS FOR CORNEAL CROSS-LINKING TREATMENTS | Avedro, Inc. | CHRISTIANSON, SKYLAR LINDSEY | 3792 | §103§112 | Non-Final OA | — | Pending | Jan 17, 2025 |
| 18913142 | INSERTION SYSTEM FOR DELIVERY OF ACTIVE PHARMACEUTICAL AGENTS INSIDE THE EYE | Glaukos Corporation | LEVY, BRANDON WILLIAM | 3781 | §103 | Non-Final OA | — | Pending | Oct 11, 2024 |
| 18663943 | PHOTOACTIVATION SYSTEMS AND METHODS FOR CORNEAL CROSS-LINKING TREATMENTS | Avedro, Inc. | MARSH, OWEN LEWIS | 3796 | §102§103§112Other | Non-Final OA | — | Pending | May 14, 2024 |
| 18606217 | OPHTHALMIC CREAM FORMULATIONS AND THEIR USES | Glaukos Corporation | VALLE, ERNESTO | 1623 | §103 | Final Rejection | — | Pending | Mar 15, 2024 |
| 18539423 | BIORESORBABLE CORNEAL IMPLANTS | Avedro, Inc. | SHARMA, YASHITA | 3774 | §103 | Final Rejection | — | Pending | Dec 14, 2023 |
| 18540296 | INTRAOCULAR PHYSIOLOGICAL SENSOR | Glaukos Corporation | PELTON, NATHANIEL R | 2859 | §102§103 | Non-Final OA | — | Pending | Dec 14, 2023 |
| 18359642 | OPHTHALMIC TOPICAL CREAM FORMULATIONS AND USES THEREOF | Glaukos Corporation | BASQUILL, SEAN M | 1614 | §103 | Final Rejection | — | Pending | Jul 26, 2023 |
| 17844497 | INTRAOCULAR PHYSIOLOGICAL SENSOR | Glaukos Corporation | TOTH, KAREN E | 3791 | §112 | Final Rejection | — | Pending | Jun 20, 2022 |
| 17125466 | OCULAR TISSUE PERFORATION DEVICE | Glaukos Corporation | MANNAN, MIKAIL A | 3774 | §103 | Final Rejection | — | Pending | Dec 17, 2020 |
| 13438705 | CONTROLLED CROSS-LINKING INITIATION AND CORNEAL TOPOGRAPHY FEEDBACK SYSTEMS FOR DIRECTING CROSS-LINKING | Avedro, Inc. | EISEMAN, LYNSEY C | 3796 | §103 | Non-Final OA | 20d | Pending | Apr 03, 2012 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial84.5% of resolved applications prosecuted by K&L Gates LLP - Chicago were allowed, across 34,332 applications in USPTO records.
3.82 office actions per allowed application on average.
10 pending office actions as of October 2026, for 2 clients, before 10 examiners in 8 art units.
